PaySign, Inc. provided earnings guidance for the year 2022. For the full year 2022, the company expects total revenue to be in the range of $35.25 million to $38.35 million, reflecting growth of 20% to 30%, with plasma making up approximately 90% of total revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.31 USD | +7.48% |
|
+9.39% | +53.93% |
13/05 | Barrington Raises Price Target on Paysign to $7 From $5.50, Keeps Outperform Rating | MT |
08/05 | Maxim Adjusts Paysign's Price Target to $6 From $5.50, Keeps Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.93% | 228M | |
+12.20% | 87.2B | |
-5.50% | 60.7B | |
-16.63% | 40.01B | |
-23.86% | 24.68B | |
-5.73% | 18.72B | |
-27.21% | 10.51B | |
-22.03% | 8.83B | |
-23.12% | 7.9B | |
-8.95% | 7.42B |
- Stock Market
- Equities
- PAYS Stock
- News Paysign, Inc.
- PaySign, Inc. Provides Earnings Guidance for the Year 2022